Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

TSXV:VPT - Post Discussion

View:
Post by canon12345 on Jan 27, 2021 4:45am

Nice start

1. Word is slowly getting out about the potential this company has. The overall market for this product has expanded 2 or 3 fold since the introduction of the vms 3.0.
2. Dr Adams initial target market is hospitals in the U.S, Canada and Europe. He estimates that there is a need for 40,000 units in those markets for existing medical conditions. Fda (or similiar) approval has been received in all those countries and units are now being used/tested in several major hospitals in these initial markets. To date reviews are all positive.    
3. The Chinese market is also now being initiated with a partner in place in China and units being tested in hospitals there. The market there could be even larger then the market in 2.
4. Looking at the markets in 2&3 we can only speculate about other large markets and there potential (ie: India, Brazil etc. etc.). Interest has been expressed by other countries.
5. Covid longhaulers have greatly increased the need for this product and as we all know the need is growing on a daily basis. The 3.0 cannot get out fast enough to help in this area.
6. The Vet market is now also being tested. Animals (Dogs, Horses etc.) all have the same heart issues as we do. Again this market is in its very early stages but the 3.0 seems especially well suited to this market given how quick of a procedure it is and that the 3.0 does not require patients to remain completely still.
7. As you can see Ventripoint is only just now gaining market traction but Dr. Adams has made great strides in getting the product to key markets that will lead to overall market acceptance and use.
8. Nice start......... enormous potential!
Comment by Banderas1209 on Jan 27, 2021 4:54am
Wonderful post Just 3 more things: 1. cashflow is sufficient for 2021 2. alliance will be announced soon 3. china sales will come sooner then later
Comment by Sunvalley on Jan 27, 2021 5:59am
Where did the original "nice start" post go by 12345? Was here earlier but when I went to review it , it was gone. Anyone?
Comment by O12009 on Jan 27, 2021 7:21am
  I still got it. You sure you don't have him on ignore. 
Comment by Sunvalley on Jan 27, 2021 7:45am
Thanks 012009, I,ll check that. How do you "unignore"?
Comment by O12009 on Jan 27, 2021 8:35am
  Hit the little image that takes you in to your setup  next hit message and then hit ignore and all the people you have on ignore comes up. Check the box and save
Comment by Sunvalley on Jan 27, 2021 9:19am
Many thanks 012009!
Comment by DennisG on Jan 27, 2021 8:18am
3. The Chinese market is also now being initiated with a partner in place in China and units being tested in hospitals there. The market there could be even larger then the market in 2. This one you got wrong, correction it's being reversed engineer in China. hahahaha
Comment by invest2profit on Jan 27, 2021 8:47am
Thanks for this. Word is getting out quick. Look at those bids this morning!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities